Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 1038 | Longs Won 605/956 63% | Profit Factor 1.47 |
| Profitability | Shorts Won 36/82 43% | Standard Deviation $3,791.38 |
| Average Win $806.3 | Best Trade (Mar 13) $62,432.28 | Sharpe Ratio -101.43 |
| Average Loss -$888.08 | Worst Trade (Oct 15) -$56,308.71 | Z-Score -11.82 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1d | Expectancy $104.27 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.1% | 0.81% | 2.72% | 6.44% | 12.55% | 21.67% | 34.37% | 51.27% | 72.95% |
| Consecutive Losing Trades | 235 | 211 | 188 | 164 | 141 | 117 | 94 | 70 | 47 | 23 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | -1,216.17 | $234,198.08 | $260,163.32 | - | -$25,965.24 | -11.09% | -9.548% |